Febuxostat: a novel agent for management of hyperuricemia in gout.

about

Febuxostat: a novel agent for management of hyperuricemia in gout.

Item

http://www.wikidata.org/entity/Q36345980

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Febuxostat: a novel agent for management of hyperuricemia in gout.

@ast

Febuxostat: a novel agent for management of hyperuricemia in gout.

@en

type

Item

label

Febuxostat: a novel agent for management of hyperuricemia in gout.

@ast

Febuxostat: a novel agent for management of hyperuricemia in gout.

@en

prefLabel

Febuxostat: a novel agent for management of hyperuricemia in gout.

@ast

Febuxostat: a novel agent for management of hyperuricemia in gout.

@en

P1476

Febuxostat: a novel agent for management of hyperuricemia in gout.

@en

P2093

Manisha Bisht

http://www.w3.org/2001/XMLSchema#string

S S Bist

http://www.w3.org/2001/XMLSchema#string

P2860

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase.

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Incidence and risk factors for gout in white men.

Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers.

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment.

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

Febuxostat--treatment for hyperuricemia and gout?

P304

597-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0250-474X.100231

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23112391

http://www.w3.org/2001/XMLSchema#string

P932

3480742

http://www.w3.org/2001/XMLSchema#string